Cain Quoted on JOBS Act

28 March 2012 Genetic Engineering & Biotechnology News News

Genetic Engineering & Biotechnology News

Partner Christopher Cain said the Jumpstart Our Business Startups (JOBS) Act will potentially create a diverse investor base that makes non-venture capital funding an effective option for biopharma startups trying to raise money. Cain also said the JOBS Act’s crowdfunding provision can help biopharmas raise supplementary funds for clinical trials, patent applications and company growth that may attract additional investments.

Click here to read the complete article.

Related Services

Insights